Latest Exact Sciences News & Updates

See the latest news and media coverage for Exact Sciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Exact Sciences

Cancer screening and diagnostic test company

exactsciences.com

Headquarters: Madison, United States
Company type: Public company
Number of employees: 5,000–10,000
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Exact Sciences

In short: Exact Sciences was acquired by Abbott for $23 billion and reported record 2025 revenues, though it recently faced a major cyber attack.

Company announcements

July 7 Exact Sciences

Exact Sciences expands Cancerguard test access in Japan

The multi-cancer early detection test is now available to patients in Japan following a team effort.

February 13 Exact Sciences

Exact Sciences achieves record 2025 revenue

Revenue grew 18% to $3.25B, with Screening and Precision Oncology both strong.

February 3 Exact Sciences

Exact Sciences' Oncotype DX test surpasses two million patients worldwide

The milestone underscores its role as a global standard-of-care, helping an estimated 1.6 million patients avoid potentially unnecessary chemotherapy.

February 2 Exact Sciences

Exact Sciences applauds passage of MCED coverage legislation

The law establishes a Medicare coverage pathway for multi-cancer early detection tests, potentially expanding access to Cancerguard for millions.

Media coverage

July 22 Wisconsin State Journal

Exact Sciences' legacy cancer diagnostics data hit in cyber attack

Abbott Laboratories, which purchased Exact Sciences for $23 billion in March, said the company's cancer diagnostics business was targeted.

July 16 Yahoo Finance

Abbott reports diagnostics growth since $21B Exact Sciences buy

Sales of Cologuard, Exact’s colorectal cancer screening test, grew in the mid-teens in the quarter. ...

March 9 Reuters

Abbott trims 2026 profit forecast on Exact deal hit, shares fall | Reuters

Abbott cut its annual profit forecast on Thursday due to an impact from its $23 billion acquisition of cancer test maker Exact Sciences, sending its...

20 November 2025 Barron's

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories

Shares of the cancer diagnostics company Exact Sciences surged 25% late Wednesday, after a report said the conglomerate Abbott Laboratories is close to a deal...

Never miss news about Exact Sciences

Track Exact Sciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Exact Sciences competitors & trending companies

Browse news for competitors to Exact Sciences and other trending companies.